XERS
$11.13+1.64%
Xeris Biopharma Holdings Inc.Stock · HealthcareRussell 2000 · 0.04% of IWMRussell 3000 · 0.002% of IWVUS Stock Market · 0.002% of VTI
Xeris Biopharma Holdings Inc. monthly returns
Xeris Biopharma Holdings Inc. has averaged 1.88% per month, positive in 56% of months. Month-by-month returns for Xeris Biopharma Holdings Inc. (XERS) below, through October 20, 2026 — the table lists the most recent months; the bar chart plots the last 5 years.
Average month
+1.9%
94 months
Best month
+90.4%
May 2020
Worst month
-48.2%
Jun 2020
Positive months
56%
of all months
Xeris Biopharma Holdings Inc. monthly returns#
| Month | Path | Total return |
|---|---|---|
| Oct 2026 | +16.4% | |
| Sep 2026 | +13.3% | |
| Aug 2026 | +4.5% | |
| Jul 2026 | +2.0% | |
| Jun 2026 | +28.6% | |
| May 2026 | +0.5% | |
| Apr 2026 | +5.7% | |
| Mar 2026 | -5.2% | |
| Feb 2026 | -16.8% | |
| Jan 2026 | -6.2% | |
| Dec 2025 | +9.3% | |
| Nov 2025 | -26.0% | |
| Oct 2025 | +19.2% | |
| Sep 2025 | +4.0% | |
| Aug 2025 | +53.8% | |
| Jul 2025 | +9.0% | |
| Jun 2025 | -5.5% | |
| May 2025 | +8.1% | |
| Apr 2025 | -16.8% | |
| Mar 2025 | +43.3% | |
| Feb 2025 | +7.6% | |
| Jan 2025 | +5.0% | |
| Dec 2024 | +3.4% | |
| Nov 2024 | +1.9% | |
| Oct 2024 | +13.0% | |
| Sep 2024 | +1.4% | |
| Aug 2024 | +13.3% | |
| Jul 2024 | +10.2% | |
| Jun 2024 | -0.4% | |
| May 2024 | +29.1% | |
| Apr 2024 | -20.8% | |
| Mar 2024 | -28.2% | |
| Feb 2024 | +25.2% | |
| Jan 2024 | +4.7% | |
| Dec 2023 | +26.3% | |
| Nov 2023 | +1.6% | |
| Oct 2023 | -1.6% | |
| Sep 2023 | -18.1% | |
| Aug 2023 | -13.0% | |
| Jul 2023 | -0.4% | |
| Jun 2023 | +2.3% | |
| May 2023 | +13.3% | |
| Apr 2023 | +38.7% | |
| Mar 2023 | +18.1% | |
| Feb 2023 | +11.3% | |
| Jan 2023 | -6.8% | |
| Dec 2022 | -11.3% | |
| Nov 2022 | -6.3% | |
| Oct 2022 | +2.6% | |
| Sep 2022 | -6.6% | |
| Aug 2022 | +17.6% | |
| Jul 2022 | -7.8% | |
| Jun 2022 | -30.3% | |
| May 2022 | -9.4% | |
| Apr 2022 | -4.7% | |
| Mar 2022 | +7.6% | |
| Feb 2022 | +12.8% | |
| Jan 2022 | -28.0% | |
| Dec 2021 | +40.2% | |
| Nov 2021 | +12.4% | |
| Oct 2021 | -24.1% | |
| Sep 2021 | -11.2% | |
| Aug 2021 | -10.1% | |
| Jul 2021 | -24.6% | |
| Jun 2021 | +30.4% | |
| May 2021 | -18.5% | |
| Apr 2021 | -15.1% | |
| Mar 2021 | -17.2% | |
| Feb 2021 | +7.3% | |
| Jan 2021 | +3.3% | |
| Dec 2020 | +12.8% | |
| Nov 2020 | -7.8% | |
| Oct 2020 | -20.2% | |
| Sep 2020 | +25.9% | |
| Aug 2020 | +64.7% | |
| Jul 2020 | +7.5% | |
| Jun 2020 | -48.2% | |
| May 2020 | +90.4% | |
| Apr 2020 | +38.5% | |
| Mar 2020 | -45.2% | |
| Feb 2020 | -44.1% | |
| Jan 2020 | -9.6% | |
| Dec 2019 | -21.1% | |
| Nov 2019 | +9.2% | |
| Oct 2019 | -16.8% | |
| Sep 2019 | -15.2% | |
| Aug 2019 | -0.9% | |
| Jul 2019 | +2.3% | |
| Jun 2019 | +4.3% | |
| May 2019 | +7.5% | |
| Apr 2019 | +1.6% | |
| Mar 2019 | +0.3% | |
| Feb 2019 | -27.9% | |
| Jan 2019 | -18.4% | |
| Dec 2018 | -18.3% | |
| Nov 2018 | -5.1% | |
| Oct 2018 | +24.7% | |
| Sep 2018 | -31.6% | |
| Aug 2018 | +41.2% | |
| Jul 2018 | -4.1% |
Monthly total return (since Nov 2021)#
-40%-20%0%20%40%
Nov 2021+12%
Dec 2021+40%
Jan 2022-28%2022
Feb 2022+13%
Mar 2022+7.6%
Apr 2022-4.7%
May 2022-9.4%
Jun 2022-30%
Jul 2022-7.8%
Aug 2022+18%
Sep 2022-6.6%
Oct 2022+2.6%
Nov 2022-6.3%
Dec 2022-11%
Jan 2023-6.8%2023
Feb 2023+11%
Mar 2023+18%
Apr 2023+39%
May 2023+13%
Jun 2023+2.3%
Jul 2023-0.38%
Aug 2023-13%
Sep 2023-18%
Oct 2023-1.6%
Nov 2023+1.6%
Dec 2023+26%
Jan 2024+4.7%2024
Feb 2024+25%
Mar 2024-28%
Apr 2024-21%
May 2024+29%
Jun 2024-0.44%
Jul 2024+10%
Aug 2024+13%
Sep 2024+1.4%
Oct 2024+13%
Nov 2024+1.9%
Dec 2024+3.4%
Jan 2025+5.0%2025
Feb 2025+7.6%
Mar 2025+43%
Apr 2025-17%
May 2025+8.1%
Jun 2025-5.5%
Jul 2025+9.0%
Aug 2025+54%
Sep 2025+4.0%
Oct 2025+19%
Nov 2025-26%
Dec 2025+9.3%
Jan 2026-6.2%2026
Feb 2026-17%
Mar 2026-5.2%
Apr 2026+5.7%
May 2026+0.49%
Jun 2026+29%
Jul 2026+2.0%
Aug 2026+4.5%
Sep 2026+13%
Oct 2026+16%
Xeris Biopharma Holdings Inc. returns by calendar month#
Every month of every year since 2019, one tick per year on a shared scale; the dark bar is the month's average. Total returns, dividends reinvested.
October 2026 so far: +16.42% — 2nd of 8 Octobers since 2019 at the last close; the average October returned -4.0%.
| Month | −95%0+95% | Average | Median | Up | Best | Worst |
|---|---|---|---|---|---|---|
| Jan | -7.0% | -6.5% | 38% | +5.0% 2025 | -28.0% 2022 | |
| Feb | -3.1% | +7.4% | 63% | +25.2% 2024 | -44.1% 2020 | |
| Mar | -3.3% | -2.5% | 50% | +43.3% 2025 | -45.2% 2020 | |
| Apr | +3.4% | -1.5% | 50% | +38.7% 2023 | -20.8% 2024 | |
| May | +15.1% | +7.8% | 75% | +90.4% 2020 | -18.5% 2021 | |
| Jun | -2.4% | +1.0% | 50% | +30.4% 2021 | -48.2% 2020 | |
| Jul | -0.2% | +2.1% | 63% | +10.2% 2024 | -24.6% 2021 | |
| Aug | +16.2% | +8.9% | 63% | +64.7% 2020 | -13.0% 2023 | |
| Sep | -0.8% | -2.6% | 50% | +25.9% 2020 | -18.1% 2023 | |
| Oct | -4.0% | -1.6% | 43% | +19.2% 2025 | -24.1% 2021 | |
| Nov | -2.1% | +1.6% | 57% | +12.4% 2021 | -26.0% 2025 | |
| Dec | +8.5% | +9.3% | 71% | +40.2% 2021 | -21.1% 2019 |
Methodology#
Monthly returns are total returns (dividends reinvested), computed from XERS's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Xeris Biopharma Holdings Inc.'s average monthly return?
- Xeris Biopharma Holdings Inc. (XERS) has averaged about 1.88% per month, positive in roughly 56% of months. The best month was May 2020 (+90.4%) and the worst was Jun 2020 (-48.2%).
More on Xeris Biopharma Holdings Inc.
By month for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100